Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Makiron is a long-established over-the-counter (OTC) antiseptic and wound care product developed and marketed by Daiichi Sankyo Healthcare in Japan. It is primarily used for the sterilization and disinfection of minor skin injuries such as cuts, abrasions, and scratches. The flagship formulation, Makiron s, is a combination product containing benzethonium chloride (a quaternary ammonium antiseptic), chlorpheniramine maleate (an antihistamine to reduce itching), and allantoin (a tissue-repair agent). It works by disrupting bacterial cell membranes, blocking histamine receptors to alleviate inflammation, and promoting skin regeneration. The product line has expanded to include specialized formulations for acne and various ointments and lotions, maintaining a significant presence in the Japanese consumer healthcare market.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Makiron.